Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The depot effect is an immunological process associated with certain vaccine formulations, particularly those containing adjuvants. It describes the localized retention and slow release of antigen at the injection site, thought to prolong immune stimulation and enhance humoral responses. While historically considered a key mechanism, particularly for aluminum-based adjuvants, its importance is now debated, with evidence suggesting that other mechanisms, such as enhanced APC recruitment or direct immune cell activation, may play more significant roles.
The depot effect describes a localized retention of antigen at the injection site for slow release and prolonged immune stimulation. While historically considered a primary mechanism for adjuvants like alum, recent evidence suggests alternative or complementary mechanisms may be more important for some adjuvants.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Enhancement via Depot Effect for Slow Antigen Release.